Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IWG Plc Director's Dealing 2019

Jun 18, 2019

6276_dirs_2019-06-18_51e48bce-578b-40ba-925c-ceb19591d5aa.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5363C

IWG PLC

18 June 2019

IWG plc (the "Company") 

Transaction notification 

1. 

Details of PDMR / person closely associated with them ("PCA") 

a) 

Name 

Estorn Limited 

b) 

Position / status  

Person closely associated with Mark Dixon, CEO (100% owned company)

c) 

Initial notification / amendment 

Initial notification

2. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 

a)  

Description of the financial instrument  

Ordinary shares of IWG plc 

b) 

Nature of the transaction 

Purchase of ordinary shares

c)  

Price(s) and volume(s) 

Price(s) GBP Volume(s)
3.40000

 3.40000

 3.40000

 3.40000

 3.40000

 3.39950

 3.40000

 3.40000

 3.40000

 3.39950

 3.40000

 3.40000

 3.40000
2,705

 3,991

1102

2204

566

2937

4003

1492

 2,204

1543

1630

6646

11057

d) 

Aggregated information  

·      Aggregated volume  

·      Price  

Total number of shares 42080

Weighted average price GBP 3.40

Of which

BATP

Volume 19000

Weighted average price GBP 3.40

CHID

Volume 3747

Weighted average price GBP 3.40

XPOS

Volume 19333

Weighted average price GBP 3.40

e)

Date of the transaction 

2019-06-17 GMT

f) 

Place of the transaction  

Exchanges:, BATP, CHID, XPOS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHCKODQOBKDAAD